- Conditions
- B-Cell Non-Hodgkins Lymphoma, Cytokine Release Syndrome, Disease Attributes, +17 more
- Locations
-
- Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
- Community Cancer Institute (CCI) Clovis, California, United States
- Providence Medical Foundation Fullerton, California, United States
- Los Angeles Cancer Network Glendale, California, United States
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,308 public trials
520 recruiting studies
Recurrence trial results
NCT07221253
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Tucson, Arizona, United States
- Research Site Duarte, California, United States
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
NCT07082803
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Stanford Medicine Cancer Center Palo Alto, California, United States
- The START Center for Cancer Care - Midwest Grand Rapids, Michigan, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012
NCT06565689
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Recruiting
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
NCT06810778
- Conditions
- Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States
NCT07257419
- Conditions
- Disease Attributes, Hematologic Diseases, Hematologic Malignancy, +17 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
NCT03618550
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- City of Hope Cancer Center (Data Collection Only) Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Miami Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
Recruiting
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
NCT07209449
- Conditions
- Disease Attributes, Endometrial Cancer, Endometrial Neoplasms, +14 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
NCT07297979
- Conditions
- Disease Attributes, Ewing Sarcoma, Neoplasms, +10 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
- University of California Los Angeles Los Angeles, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States